New Delhi: Russia’s Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to...
Beijing: China is considering the mixing of different Covid-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert has...
Washington: Pfizer-BioNTech asked for authorization Friday to use their Covid-19 vaccine on 12-15 year olds in the United States. The companies said in a statement...
Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot Covid-19 vaccine in the country. The U.S. drugs...
Panacea Biotec shares surged on Tuesday after the company signed a deal with the Russian Direct Investment Fund (RDIF) to produce 100 million doses per...
Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF) and domestic firm, Panacea Biotec announced a tie up to produce 100 million doses per year...
Beijing: Chinese biopharmaceutical firm Sinovac said Friday a third production line for its Covid-19 vaccine has been put into use, doubling its annual capacity of...
– Pfizer Inc and BioNTech said on Thursday their Covid-19 vaccine is around 91% effective at preventing the disease, citing updated trial data that included...